Endpoint definition
↥| Name | N14_VULVOVAGINFINOTH | 
|---|---|
| Long name | Vulvovaginal ulceration/inflammation in other diseases | 
| Sex specific endpoint | 2 | 
| Level in the ICD-hierarchy | 3 | 
| First defined in version | DF2 | 
| Name | N14_VULVOVAGINFINOTH | 
|---|---|
| Long name | Vulvovaginal ulceration/inflammation in other diseases | 
| Sex specific endpoint | 2 | 
| Level in the ICD-hierarchy | 3 | 
| First defined in version | DF2 | 
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 631 | 631 | - | 
| Unadjusted prevalence (%) | 0.29 | 0.51 | - | 
| Mean age at first event (years) | 37.08 | 37.08 | - | 
| Case fatality at 5-years (%) | 0.63 | 0.63 | - | 
| All | Female | Male | |
|---|---|---|---|
| Median nb. of events per indiv. | 1.0 | 1.0 | - | 
| Recurrence at 6 months (%) | 9.03 | 9.03 | - | 
						 before Vulvovaginal ulceration/inflammation in other diseases
						
						 after Vulvovaginal ulceration/inflammation in other diseases
					
Loading survival analyses plot…
Loading survival analyses table…